Does the diagnosis of trachoma adequately identify ocular chlamydial infection in trachoma-endemic areas?

Journal of Infectious Diseases

Volumn 187, Issue 10, 2003, Pages 1669-1673

  Bird, Mariko ^a   Dawson, Chandler R ^a,b   Schachter, Julius S ^a,b   Miao, Yinghui ^a   Shama, Ahmed ^c   Osman, Ahmed ^c   Bassem, Ahmad ^c   Lietman, Thomas M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; TETRACYCLINE;

ADOLESCENT; ARTICLE; CHILD; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE MARKER; DNA DETERMINATION; HUMAN; LIGASE CHAIN REACTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TRACHOMA;

ADOLESCENT; AGE FACTORS; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHILD; CHILD, PRESCHOOL; CHLAMYDIA TRACHOMATIS; EGYPT; HUMANS; INFANT; TETRACYCLINE; TRACHOMA;

EID: 0037569199     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/374743     Document Type: Article

References (15)

1. World Health Organization (WHO). Report of the 1st meeting of the WHO Alliance for the Global Elimination of Trachoma. Geneva, Switzerland: WHO, 1997.
2. Schachter J, West SK, Mabey D, et al. Azithromycin in control of trachoma. Lancet 1999; 354:630-5.
3. Taylor HR. A trachoma perspective. Ophthalmic Epidemiol 2001; 8:69-72.
4. Dawson C, Marx, R, Daghfous, R, Juster R, Schachter, J. What clinical signs are critical in evaluating the impact of intervention in trachoma? In: Chlamydial infections: proceedings of the 7th international symposium on human chlamydial infection (Harrison Hot Springs, British Columbia, Canada). Cambridge: Cambridge University Press, 1990:271-8.
5. Thylefors B, Dawson CR, Jones BR, West SK, Taylor HR. A simple system for the assessment of trachoma and its complications. Bull World Health Organ 1987; 65:477-83.
6. Taylor HR, Rapoza PA, West S, Johnson S, Munoz B, Katala S. The epidemiology of infection in trachoma. Invest Ophthalmol Vis Sci 1989; 30:1823-33.
7. Baral K, Osaki S, Shreshta B, et al. Reliability of clinical diagnosis in identifying infectious trachoma in a low-prevalence area of Nepal. Bull. World Health Organ 1999; 77:461-6.
8. Laming AC, Hallsworth PJ. Detection of chlamydial nucleic acid in follicular trachoma. Med J Aust 1999; 170:190.
9. Lietman T, Dawson C, Osaki S, Zegans M. Clinically active trachoma versus Chlamydia infection. Med J Aust 2000; 172:93-4.
10. Bobo LD, Novak N, Muñoz B, Hsieh YH, Quinn TC, West S. Severe disease in children with trachoma is associated with persistent Chlamydia trachomatis infection. J Infect Dis 1997; 176:1524-30.
11. Bailey RL, Hayes L, Pickett M, Whittle HC, Ward ME, Mabey DC. Molecular epidemiology of trachoma in a Gambian village. Br J Ophthalmol 1994; 78:813-7.
12. Ward M, Bailey R, Lesley A, Kajbaf M, Robertson J, Mabey D. Persisting inapparent chlamydial infection in a trachoma endemic community in the Gambia. Scand J Infect Dis Suppl 1990;69:137-48.
13. World Health Organization (WHO). Report of the 6th meeting of the WHO Alliance for the Global Elimination of Trachoma. Geneva, Switzerland: WHO, 2001.
14. Bailey RL, Arullendran P, Whittle HC, Mabey DC. Randomised controlled trial of single-dose azithromycin in treatment of trachoma. Lancet 1993; 342:453-6.
15. Diamant J, Benis R, Schachter J, et al. Pooling of chlamydial laboratory tests to determine prevalence of trachoma. Ophthalmic Epidemiol 2001;8:109-17.